Komori

Presentation Materials for the First Quarter of the Fiscal Year Ending March 2026

Results presentationFirst quarter, FY ending Mar 2026Published 2025-08-14 15:30

第1四半期は売上高・各利益が前年同期を上回り、過去最高を更新した。価格改定後も診療数が堅調だったため、2026年3月期の通期業績予想を売上高・利益とも上方修正した。

Contents of this document

Earnings presentationFirst quarter of the fiscal year ended March 20269 items taken from the company’s own explanation
Financial Results Figures (The key points of this material are explained below)
Net Sales¥1,473 million+17.8%
Operating profit¥258 million+73.3%
Ordinary income¥258 million+71.2%
Net income¥180 million+75.0%
Selling, general and administrative expenses¥304 million
Gross Profit Margin
Rate38.2%
Year-on-year change (points)+4.1 percentage points
Operating profit margin
Rate17.6%
Year-on-year change (points)+5.7 percentage points
Results for the three months of the current quarter売上高1,473百万円、売上総利益563百万円、営業利益258百万円、経常利益258百万円、親会社株主に帰属する四半期純利益180百万円、EBITDA413百万円。いずれも第1四半期単独の数値。
Full-year earnings forecast
Net Sales
¥5,960 million
Operating profit
¥857 million
Ordinary income
¥857 million
Profit attributable to owners of the parent
¥610 million
Progress against full-year forecast 通期の予想に対して、いまどこまで進んだかの割合です。
Net Sales24.7%
Operating profit30.2%
Ordinary income30.1%
Profit attributable to owners of the parent29.6%
Number of initial consultations26.2%
What the company explained in this material
Self-assessment against the planThe company's self-assessment against its own plan.
計画通り(下期の投資拡大・費用増について)
Breakdown of Factors Affecting the ChangeReasons cited by the Company for the change in the figures.
Revenue increase+¥222 million
Personnel Expenses-¥61 million
Facilities and IT-¥21 million
Depreciation and amortization-¥11 million
Other-¥20 million
Assumptions Underlying the Business OutlookThe assumptions used by the company in preparing its forecast.
価格改定による診療数への影響を保守的に見積もっていた。為替・原材料価格・金利などの数値前提はNot disclosed。
New initiatives
  • Renovation of Nagoya Hospital
  • 九州・福岡への展開
  • 次世代型新電子カルテシステムの設計・導入
  • AI画像診断・AI診療支援などの検討
  • 動物医療インテリジェンスプラットフォーム構想
  • 人事制度の全面刷新
  • 川崎本院のMRI更新・CT追加
Key KPIsA metric the company considers important as a management benchmark.
  • Number of initial consultations (referrals)2,762 transactions
    Year on year against the same period last year+322件(前年1,?ではなく資料上は1,?)
  • Number of affiliated hospitals4,681 facilities
    Year on year against the same period last year+180施設
  • Affiliated hospital ratio36.4 %
    Year on year against the same period last year+0.2 percentage points
  • 総診療数Record high
  • 手術数Record high
Segment results
Secondary Veterinary Care Services
Net Sales
¥1,066 million
Year on year against the same period last year+20.1%
Diagnostic Imaging Services
Net Sales
¥156 million
Year on year against the same period last year+13.0%
動物用医療機器・健康管理機器のレンタル・販売
Net Sales
¥247 million
Year on year against the same period last year+11.4%
Medium-term management plan targets
Fiscal year ending March 2027
Number of veterinarians120 people
Number of initial consultations11,604 cases
Hospital revenue¥4,550 million
Consolidated revenue6,200 million yen
Consolidated operating profit1,040百万円
ROE14% or higher
Financial targets
ROE
2026年3月期今回修正13.4%
Fiscal year ended March 202513.1%
Target for the fiscal year ending March 202714% or higher
Number of employees
Number of veterinarians
101 people
Hiring plan中途採用を強化する方針。新卒採用は好調。
Contents of this document
ItemDetails
Document typeEarnings presentation
Fiscal Period CoveredFirst quarter of the fiscal year ended March 2026
Net Sales¥1,473 million (YoY +17.8%)
Operating profit¥258 million (YoY +73.3%)
Ordinary income¥258 million (YoY +71.2%)
Net income¥180 million (YoY +75.0%)
Gross Profit MarginRate 38.2% / Year-on-year change (points) +4.1 percentage points
Operating profit marginRate 17.6% / Year-on-year change (points) +5.7 percentage points
Selling, general and administrative expenses¥304 million
Results for the three months of the current quarter売上高1,473百万円、売上総利益563百万円、営業利益258百万円、経常利益258百万円、親会社株主に帰属する四半期純利益180百万円、EBITDA413百万円。いずれも第1四半期単独の数値。
Full-year earnings forecastNet Sales ¥5,960 million / Operating profit ¥857 million / Ordinary income ¥857 million / Profit attributable to owners of the parent ¥610 million
Progress against full-year forecastNet Sales 24.7% / Operating profit 30.2% / Ordinary income 30.1% / Profit attributable to owners of the parent 29.6% / Number of initial consultations 26.2%
Self-assessment against the plan計画通り(下期の投資拡大・費用増について)
Segment resultsSecondary Veterinary Care Services Net Sales ¥1,066 million / Year on year against the same period last year +20.1% / Profit Not disclosed / Diagnostic Imaging Services Net Sales ¥156 million / Year on year against the same period last year +13.0% / Profit Not disclosed / 動物用医療機器・健康管理機器のレンタル・販売 Net Sales ¥247 million / Year on year against the same period last year +11.4% / Profit Not disclosed
Breakdown of Factors Affecting the ChangeRevenue increase +¥222 million / Personnel Expenses -¥61 million / Facilities and IT -¥21 million / Depreciation and amortization -¥11 million / Other -¥20 million
Key KPIsIndicator name Number of initial consultations (referrals) / Value 2,762 transactions / Year on year against the same period last year +322件(前年1,?ではなく資料上は1,?), Indicator name Number of affiliated hospitals / Value 4,681 facilities / Year on year against the same period last year +180施設, Indicator name Affiliated hospital ratio / Value 36.4 % / Year on year against the same period last year +0.2 percentage points, Indicator name 総診療数 / Value Record high / Year on year against the same period last year Not disclosed, Indicator name 手術数 / Value Record high / Year on year against the same period last year Not disclosed
Number of employeesNumber of veterinarians 101 people / Change during the period Not disclosed / Hiring plan 中途採用を強化する方針。新卒採用は好調。
Assumptions Underlying the Business Outlook価格改定による診療数への影響を保守的に見積もっていた。為替・原材料価格・金利などの数値前提はNot disclosed。
Medium-term management plan targetsFiscal year ending March 2027 Number of veterinarians 120 people / Number of initial consultations 11,604 cases / Hospital revenue ¥4,550 million / Consolidated revenue 6,200 million yen / Consolidated operating profit 1,040百万円 / ROE 14% or higher
Financial targetsROE 2026年3月期今回修正 13.4% / Fiscal year ended March 2025 13.1% / Target for the fiscal year ending March 2027 14% or higher
New initiativesRenovation of Nagoya Hospital, 九州・福岡への展開, 次世代型新電子カルテシステムの設計・導入, AI画像診断・AI診療支援などの検討, 動物医療インテリジェンスプラットフォーム構想, 人事制度の全面刷新, 川崎本院のMRI更新・CT追加
Items this document does not state (10)
Unit price and quantity metricsNumber of stores and locationsRisk amount incorporated into the outlookAnnual DividendPayout ratioAcquisition of treasury sharesCapital expendituresOrders received and order backlogMarket Size / ShareKey points of the Q&A

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

Presentation Materials for the First Quarter of the Fiscal Year Ending March 2026 | Japan Animal Referral Medical Center Co.,Ltd. (6039) timely disclosure | Komori